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Introduction
Osteoporosis is characterized by the reduction and deterioration of the bone microarchitecture, leading to increased bone frailty and susceptibility to fracture. The worldwide incidence of osteoporosis is increasing, and can be an economic burden on both families and societies (Kanis et al., 1994; Johnell and Kanis, 2006) . Currently, 200 million people worldwide have osteoporosis. A large number of people also have low bone mass, placing them at an increased risk for developing osteoporosis. As the population ages, these numbers will increase. A majority of those with osteoporosis are women. Of people older than 50 years, one in two women and one in eight men are predicted to have an osteoporosis-related fracture in their lifetime. Drugs being developed or used for treating osteoporosis include estrogen replacement therapy, calcitonin, selective estrogen receptor modulators, and diphosphate. Although these drugs prevent bone resorption, their effects on bone formation are extremely small (Abrahamsen et al., 2014; Bandeira et al., 2014; Chen and Kubo, 2014; Kulak et al., 2014) .
Herbal Epimdii, a popular traditional Chinese medicine, has been used to treat osteoporosis in East Asian countries for over 2000 years (Nelson et al., 2002; Wu et al., 2003) . In the perspective of modern medicine, the main pharmacological ingredients of Herbal Epimdii were found to be various prenylated epimedium flavonoids (including icariin, epimedin A, epimedin B, epimedin C, and baohuoside I) (Figure 1 ). Modern research has also confirmed that prenylated epimedium flavonoids can regulate the balance between osteogenic and adipogenic differentiation of bone marrow stromal cells in ovariectomized rats by down-regulating the expression of DKK1 protein, thereby enhancing This article has not been copyedited and formatted. The final version may differ from this version. bone formation, and can also prevent ovariectomy-induced bone loss (Xu et al., 2011; Zhang et al., 2007) . However, the oral bioavailability of epimedium flavonoids is very low Zhou et al., 2014; Wei et al., 2012) .
Our previous study found that there are several reasons for this low bioavailability.
Firstly, epimedium flavonoids have low absorptive permeabilities due to their physicochemical characteristics (Chen et al., 2008) . Secondly, they are subject to efflux by the drug transporters in intestinal mucosa, such as P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and multidrug resistance-associated protein (MRP) Wolfgang et al., 2005) . Thirdly, these flavonoids can be hydrolyzed by hydrolase in the intestinal mucosa and flora. Lactase phlorizin hydrolase (LPH) and β -glucosidase were confirmed as the main hydrolases in intestinal mucosa and flora, which could hydrolyze the epimedium flavonoids to secondary glycosides or aglycon (Cui et al., 2013; Qian et al., 2012; Zhao et al., 2010) . The above results were obtained with healthy animals; however, the absorption and hydrolysis behavior in osteoporotic animal remains unknown.
Therefore, we have studied the absorption and hydrolysis of epimedium flavonoids under osteoporotic conditions. In this study, we explored the absorption and hydrolysis characteristics of icariin, epimedin A, epimedin B, epimedin C, and baohuoside I in osteoporosis rats. To analyze the hydrolysis rates of epimedium flavonoids and to detect their metabolites, they were incubated in vitro with rat intestinal mucosa and feces at 37°C.
The absorption of epimedium flavonoids was investigated using an in situ intestinal perfusion model. With these methods, the absorption and hydrolysis characteristics of epimedium flavonoids in osteoporosis rats have been revealed, and the differences of This article has not been copyedited and formatted. The final version may differ from this version. 
Materials and Methods
Ethics Statement
Animal welfare and experimental procedures were strictly in accordance with the Guide for the Care and Use of Laboratory Animals (US National Research Council, 1996) and the related ethics regulations of Jiangsu Provincial Academy of Chinese Medicine.
Reagents and chemicals
Icariin (purity > 98%) was purchased from National Institute for the Control of After one week of acclimatization, rats were anesthetized with intraperitoneal (i.p.)
injection of 300 mg chloral hydrate (Sinopharm®, China)/kg body weight and then both ovaries were removed. Rats were left untreated for 3 months to allow them to recover and develop osteopenia according to a previously published method . The sham rats underwent bilateral laparotomy but the ovaries were left in place. The result of bone mineral density (BMD) of femur in rats confirmed the osteoporosis model was available for subsequent experiments (Supplemental Table 1 ).
Intestinal flora hydrolyze epimedium flavonoids
Anaerobic culture medium were prepared as follows: K 2 HPO 4 (37.5 mL, 0.78%), solution A (37.5 mL, 0.47% KH 2 PO 4 , 1.18% NaCl, 1.2% (NH 4 ) 2 SO 4 , 0.12% CaCl 2 , 0.25% MgSO 4 ·H 2 O), Na 2 CO 3 (50 mL, 8%), L-cysteine (0.5 g), L-ascorbic acid (2 mL, 25%), eurythrol (1 g), tryptone (1 g) and nutrient agar (1 g) were mixed together and diluted with distilled water to 1 L. Then the solution was adjusted pH to 7.5 -8.0 with 2 M HCl (Akao et al., 1996) .
Fresh feces collected from SD rats were immediately homogenized in normal saline solution at the ratio of 1 g to 4 mL. The homogenate was filtered, and the filtrate of fresh feces (10 mL) was added anaerobic culture medium (90 mL) to obtain an intestinal flora cultural solution. Icariin, epimedin A, epimedin B, epimedin C or baohuoside I (1 mL; 2 mM) were then added to the intestinal flora cultural solution (9 mL), respectively.
After incubation for 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 4, 6, 8, 12 and 24 h at 37°C, the incubations were deproteinized by adding a 3-fold volume of acetonitrile. The samples were vortexed for 1 min and centrifuged for 15 min at 15,000 rpm. For HPLC-UV analysis, 400
This article has not been copyedited and formatted. The final version may differ from this version. μ L aliquots of the supernatants were mixed with 100 μ M internal standard testosterone (100 μ L) which dissolved in acetonitrile. For UPLC/Q-TOF-MS analysis, the supernatants (150 µ L) were purified using a C18 solid phase extraction cartridge (Agilent, Santa Clara, CA, USA). The cartridge was activated by methanol (3 mL), and was then balanced using water (2 mL). Intestinal perfusion samples (0.6 mL) were mixed with methanol (150 μ L). The mixtures were centrifuged for 15 min at 13,000 rpm. Supernatants (0.6 mL) were added into the cartridge, and then the cartridge was eluted with water (5 mL) and methanol (5 mL). The elutropic methanol was collected and evaporated to dryness under a gentle stream of nitrogen at 30°C before being reconstituted in acetonitrile (450 μ L).
The experiments were divided into the sham group and the osteoporosis group, fresh feces was collected from both groups at 3 months post-operation.
Intestinal enzyme hydrolyze epimedium flavonoids
After overnight food deprivation, rats were anesthetized by intramuscular injection of urethane (0.5 g/mL). An incision was made into the abdominal cavity to take out the small intestine, and the intestine was immediately preserved in cold saline. After being divided into duodenum, jejunum, ileum, and colon, the contents of the four segments were removed by flushing gently with saline (0°C). Intestinal mucosa was blunt scratched. Intestinal mucosa in different segments was immediately homogenized in normal saline solution at the ratio of 1 g to 4 mL. Homogenates of intestinal mucosa (10 mL) were mixed with cold saline (90 mL) to prepare the intestinal enzyme cultural solution (Aloys et al., 2003) .
The next procedures and animal group assignment were the same as the experiments of intestinal flora hydrolyzing epimedium flavonoids. At the same time, protein was extracted 
In situ intestinal perfusion assay of epimedium flavonoids
The rats were fasted overnight but were provided with deionized water. After overnight fasting, rats were anesthetized. The small intestine was exposed by midline incision; the intestinal lumen was then gently flushed to remove intestinal contents and each of the four segments (duodenum, upper jejunum, terminal ileum, and colon) of the intestine was cannulated with two cannulas. The outlet of each segment was secured by ligation with silk suture. The intestine was carefully arranged and continuously monitored to avoid kinks, and a consistent flow should be ensured after cannulation. Saline-soaked cotton was used to cover opened body cavities to prevent loss of fluids Chen et al., 2003; Liu et al., 2002; Higaki et al., 2004 ) .
At 3-month ovariectomized postoperation, both sham rats and osteoporosis rats were operated as above steps. To keep the temperature of the perfusate constant, the inlet cannula was insulated and kept warm by a 37°C circulating water bath. A flow rate of 0.2 mL/min was used, and the perfusate samples were collected every 30 min. The outlet concentration of drug in the perfusate was determined by UPLC-UV, and the hydrolyzed products were detected by UPLC/Q-TOF-MS. The preparation method of perfusate samples was the same as the intestinal flora and enzyme samples. The initial concentration of the perfusate was 20 μ M.
Analytical Methods
UPLC-UV is a rapid and efficient method for determining the contents of different samples.
This article has not been copyedited and formatted. The final version may differ from this version. However, impurities in the intestinal flora and enzyme samples would block a UPLC-UV system. On the other hand, the perfusate samples were cleaner than intestinal flora and enzyme samples. Therefore, HPLC-UV was used for determining the contents of epimedium flavonoids in intestinal flora and enzyme samples, while UPLC-UV was used for determining the contents of epimedium flavonoids in perfusate samples, and all the metabolites were identified by UPLC/Q-TOF-MS method.
UPLC-UV method: Waters Acquity UPLC system with photodiode array detector and Empower software; column, Acquity UPLC BEH C18, 1.7 μ m, 2.1 × 50 mm (Waters, Milford, MA, USA); mobile phase A, acetonitrile; mobile phase B, water; gradient, 0 to 0.5 min, 25% A, 0.5 to 1.5 min, 25% to 28% A, 1.5 to 2.5 min, 28% A to 32%, 2.5 to 3.5 min, 32% A to 35% A, 3.5 to 4.5 min, 35% A to 55%, 4.5 to 5.5 min, 55% A to 95%, 5.5 to 6.0 min, 95% A; flow rate, 0.4 mL/min; column temperature, 30°C; injection volume, 5 μ L;
wavelength, 270 nm for epimedium flavonoids and 254 nm for internal standard testosterone. In general, these methods were selective and reproducible with day-to-day variability less than 2%. The accuracy and precision were greater than 92%. A, 1.5 to 3 min, 25% A, 3 to 4 min, 25% to 28% A, 4 to 5 min, 28% to 32% A, 5 to 6 min, 32% to 35% A, 6 to 7 min, 35% to 55% A, 7 to 8 min, 55% to 95% A, 8 to 9.5 min, 95% A, 9.5 to 10 min, 95% to 5% A, the flow rate was 0.4 mL/min; the column temperature was maintained at 30°C; the injection volume was 2 µL. The tested linear response ranges for samples were 1.25 to 40 μ M. Epimedium flavonoids exhibited good linearity within the selected concentration ranges with R 2 between 0.9992 and 0.9996.
For MS analysis, the ESI source was operated in the positive ion mode. The capillary and cone voltages were 3,000 and 20 V, respectively. The tapered bore gas was 50 L/h, the desolvation gas (nitrogen) was set to 600 L/h at 400°C, and the source temperature was 100°C.
Mass range was scanned from 100 to 1200 Da. Multireaction monitoring mode (MRM); low energy: 6V, high energy: 20-30 V.
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Data Analysis
For analyzing the hydrolysis behavior of epimedium flavonoids in intestinal flora and enzyme incubation, the hydrolysis rate of epimedium flavonoids was calculated using the following equation:
In the equation [1], A t is the total amount of epimedium flavonoids before hydrolysis;
A r is the residual amount of epimedium flavonoids after hydrolysis.
For analyzing the absorption behavior of epimedium flavonoids in intestinal perfusion, the absorption of drug was measured by the rate of its disappearance, and the apparent permeability coefficient (P * app ) was determined through the rate of drug disappearance. The P * app was calculated using the following equation:
Results
Hydrolysis of epimedium flavonoids by intestinal flora
When incubated with intestinal flora of sham and osteoporosis rats, icariin, epimedinA, epimedin B, and epimedin C were hydrolyzed rapidly. HPLC-UV demonstrated that each of them had only one metabolite (Supplemental Figure 2) . UPLC/Q-TOF-MS revealed that the metabolites of the four flavonoids were the 7-deglucosed products, baohuoside I (icariin), sagittatosideA (epimedin A), sagittatoside B (epimedin B), and 2''-O-rahmonosylicarside II (epimedin C). The metabolites of the sham and osteoporosis groups were the same.
Although the metabolites in the two groups were similar, the hydrolysis rates were different. To measure the hydrolysis rate of epimedium flavonoids, rates measured at The metabolites that were generated were also measured to evaluate the hydrolysis capability of intestinal enzymes. As shown in Figure 4 , the amounts of metabolites of epimedium flavonoids incubated with four different intestinal segments were higher in the sham rats than the osteoporosis rats. Metabolites of icariin, baohuoside I and RPI, were detected after incubation with enzyme from duodenum, jejunum, and ileum for both groups.
After incubation with colon enzymes, only baohuoside I could be found in the sham group, and RPI was not detected in either group. Moreover, the amount of baohuoside I increased respectively) of sham rats was also higher than that of ovariectomized rats (48.61 ± 6.76%, 29.16 ± 3.05%, 7.18 ± 1.70%, and 3.34 ± 0.68%, respectively) (vs. the corresponding bowel, P < 0.05). Under the two condition, from duodenum to colon, the P * app and 10 cm% EP decreased sequentially. The amounts of epimedin A in the four intestinal segments were decreased in turn from duodenum to colon (Figure 6 ). The amounts of sagittatoside A in the sham group were much greater than that of the osteoporosis group at the relevant intestinal segments.
In sham rats' duodenum, jejunum, ileum, and colon, the P * app values of epimedin B were 3.52 ± 0.17, 2.44 ± 0.19, 0.60 ± 0.11, and 0.42 ± 0.04, respectively, and the 10 cm% EP values were 66.35 ± 3.15%, 45.18 ± 2.43%, 11.17 ± 2.43%, and 7.83 ± 0.66%, respectively. In osteoporosis rats' duodenum, jejunum, ileum, and colon, the P * app values of epimedin B were 2.11 ± 0.13, 1.20 ± 0.13, 0.36 ± 0.04, and, 0.23 ± 0.04, respectively, and the 10 cm% EP values were 39.75 ± 3.07%, 23.09 ± 2.47%, 6.91 ± 1.63%, and 4.33 ± 0.73%, respectively. These findings show that for both sham and osteoporosis rats, the P * app of epimedin B in duodenum, jejunum, ileum, and colon fell and, in turn, so did the 10cm% EP of epimedin B. Compared to the sham group, the P * app and 10 cm% EP values of epimedin B in the osteoporosis group decreased remarkably (vs. the corresponding bowel, P < 0.05). The amount of sagittatoside B was highest in the duodenum and lowest in the colon.
The sagittatoside B's content was reduced in osteoporosis group (Figure 7) .
In osteoporosis rats' duodenum, jejunum, ileum, and colon, the P With the exception of baohuoside I, whose absorption was unchanged, we found that after oral administration of epimedium flavonoids, most of them were hydrolyzed to secondary glycoside or aglycon by enzymes in the intestine, which led to increased absorption.
The enzymes in the intestine have two main sources, intestinal mucosa and intestinal bacteria.
When epimedium flavonoids are orally administered, they reach the stomach first. Our earlier studies showed that the main flavonoids in epimedium could not be hydrolyzed by gastric juice (Gao et al., 2013) . Hence, the main absorption site of epimedium flavonoids is in the small intestine. In human and rat small intestine (from duodenum to ileum), there are two kinds of β -glucosidase, cytosolic β -glucosidase (CBG) and lactose root phlorizin hydrolase (LPH) that could hydrolyze epimedium flavonoids (Nemeth et al., 2003) . Both of them could hydrolyze the β -glycosidic bonds of glycosides, albeit by substantially different hydrolysis mechanisms (Nemeth et al., 2003) . For the CBG hydrolysis pathway, because it is an intracellular enzyme, the glycosides must be transported into cells and then hydrolyzed. In our preliminary research, we found that prototypes of epimedium flavonoids had poor membrane permeability and had a slow uptake by intestinal cells. In addition, it was reported that the transporter of glycoside substances such as SLTGT1 could not transport flavonoids into cells (Dongmei et al., 2012) . Therefore, it could be inferred that epimedium flavonoid hydrolysis was not the role of CBG. LPH, a type of extracellular enzyme that is located in the brush border of the small intestinal epithelium, is the only β -glucosidase in mammalian intestinal brush border. There are two distinct active sites of LPH for catalytic hydrolysis, one for hydrolyzing lactose and flavonoids, and the other for hydrolyzing phlorizin and β -glucosylceramidase (Tseung et al., 2004) . Because LPH is located in the brush border of the small intestinal epithelium (Nemeth et al., 2003) , the flavonoids could be hydrolyzed by LPH once they enter the small intestine. Our previous experiments also confirmed that the hydrolysis of epimedium flavonoids decreased after adding LPH inhibitors , indicating that LPH in intestinal mucosa is the major hydrolase that hydrolyzes epimedium flavonoids. However, the above experiments were carried out on healthy rats, and it was not possible to determine whether the hydrolysis capability of LPH would be different in pathological state.
Because epimedium flavonoids have a good effect against osteoporosis, we studied the hydrolysis capability of LPH in the osteoporotic animals. Our experimental results showed that the hydrolysis rates of epimedium flavonoids in osteoporosis rats was slower than in sham rats, whether the flavonoids were incubated with intestinal enzyme in vitro or were conducted by the in situ intestinal perfusion. These results indicated that the amount and activity of LPH might be lower in osteoporosis rats. Later, the experiment of LPH expression testified our hypothesis that LPH expression was indeed down-regulated in the This article has not been copyedited and formatted. The final version may differ from this version. ovariectomized rats. Besides, it has been reported that high incidence of fractures and low bone mineral density in menopausal women are correlated with decreased activity and expression of LPH (Bacsi et al., 2007) , and the activity of LPH in senile osteoporosis patients is greatly reduced, or even completely inactivated (Bacsi et al., 2007) . Both our results and the literatures confirm that low LPH expression is the major factor which decreases the epimedium flavonoid hydrolysis and affects the absorption of flavonoids and their utilization by the body.
In addition to enzymes from intestinal mucosa, enzymes from micro-organisms are involved in the hydrolysis of epimedium flavonoids in the intestinal tract. There were about 100 trillion bacteria in the bowel, of which more than 99% areanaerobic bacteria, including species from the Bacteriodacae, Cattenabacterium, Peptostreptococcus, and Spirillaceal families. Different species of bacteria secrete different metabolic enzymes, and are thereby involved in different types of drug metabolism. For example, there are many bacteria (e.g.
Escherichia coli, Enterococcus, etc.) that secrete β -glucosidase, which can hydrolyze β -glucoside bonds for the purpose of detoxification or easier absorption. Epimedium flavonoids that are not fully hydrolyzed in the small intestine travel into the large intestine, where they are for re-absorbed following hydrolysis by bacteria located there. However, owing to the complexity of the intestinal flora, the relationship of intestinal flora and osteoporosis needs to be studied further (Claesson et al., 2012; Koren et al., 2012) .
As the body's largest and most sophisticated micro-ecosystem, maladjusted intestinal bacteria might cause disease, and then the disease could in turn change the function of bacteria (Murphy et al., 2013; Sekirov et al., 2010; Shen et al., 2012; Zhao et al., 2013) .
This article has not been copyedited and formatted. The final version may differ from this version. This could explain the reduced hydrolysis rates of icariin, epimedin A, epimedin B, and epimedin C in the intestinal flora of osteoporosis rats, as compared to that observed for sham rats. The above results indicated that intestinal bacteria activity decreased because of the pathological conditions of osteoporosis. Some previous reports in the literature are consistent with our results. It has been reported that the number of anaerobic bacteria, especially Lactobacillus, was significantly lower than normal in osteoporosis rats, and the colonization ability of anaerobic bacteria in the intestine was decreased. With respect to metabolism, the ability of bacterial hydrolysis of the glycosidic bonds in general is reduced due to changes in flora and preference for carbon source (Ishihara et al, 2002) . 
Conclusions
In this study, we found that the intestinal absorption and hydrolysis of epimedium flavonoids was slower in osteoporosis rats than in the sham rats. The ovariectomization of rats resulted in osteoporosis, which might affect the activities of intestinal enzymes, and the number of intestinal flora. These changes can then affect the intestinal absorption and hydrolysis of epimedium flavonoids whose structures contain glycosylations.
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